All stock lists
Nuvectis Pharma, Inc. (NASDAQ:NVCT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
18.49-1.56 (-7.78%)
Insider Score
––Not scored
NVCT Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
NVCT Stock Insider Trading Activity
NVCT stock’s insider trading shows 2 purchases for an estimated $1.17M by company insiders over the last 6 months.
Not enough price history.
Insider Trading Activity (Form 4 Filings)
An insider trade occurs when an individual that has non-public information about a company buys or sells shares of that company’s stock. Examples of insiders include a company’s executive officers (CEO, CFO, COO), its board of directors, and its major shareholders. Insiders are required to submit their trading activity to the SEC through Form 4 filings.
| Insider | Action | Shares | Avg Cost | Total | Δ Holdings | Held After | Date | Grade | Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Carson Michael J. Other | Award | 30,000 | — | — | 15.0% | 230,118 | Aug 3, 2026 | — | Form 4 |
| BENTSUR RON CEO | Buy | 12,500 | $20.00 | $250.00K | 0.3% | 3,688,424 | Jun 30, 2026 | BCEO BuyDilution | Form 4 |
| Mosseri Marlio Charles Other | Buy | 50,000 | $18.32 | $916.00K | 1.6% | 3,186,576 | Jun 30, 2026 | — | Form 4 |
| Hoberman Kenneth Director | Award | 35,000 | — | — | 26.3% | 168,140 | Jun 11, 2026 | — | Form 4 |
| Oliviero James F III Director | Award | 35,000 | — | — | 39.9% | 122,828 | Jun 11, 2026 | — | Form 4 |
| Kaplan Matthew L. Director | Award | 35,000 | — | — | 28.1% | 159,760 | Jun 11, 2026 | — | Form 4 |
| Sanchez Juan Director | Award | 35,000 | — | — | 44.7% | 113,380 | Jun 11, 2026 | — | Form 4 |
| BENTSUR RON CEO | Award | 150,000 | — | — | 4.3% | 3,675,924 | Jan 6, 2026 | — | Form 4 |
| Shemesh Shay Other | Award | 150,000 | — | — | 9.1% | 1,793,068 | Jan 6, 2026 | — | Form 4 |
| Poradosu Enrique Other | Award | 150,000 | — | — | 9.1% | 1,806,319 | Jan 6, 2026 | — | Form 4 |
| Carson Michael J. Other | Award | 61,200 | — | — | 44.1% | 200,118 | Jan 6, 2026 | — | Form 4 |
| Kaplan Matthew L. Director | Buy | 11,000 | $5.84 | $64.24K | 9.7% | 124,760 | Nov 5, 2025 | CCluster BuyFirst BuyDilution | Form 4 |
| Sanchez Juan Director | Buy | 13,000 | $5.79 | $75.27K | 20.0% | 78,150 | Nov 5, 2025 | CCluster BuyFirst BuyDilution | Form 4 |
| BENTSUR RON CEO | Buy | 5,000 | $5.72 | $28.60K | 0.1% | 3,525,924 | Nov 5, 2025 | CCluster BuyFirst BuyDilution | Form 4 |
| Mosseri Marlio Charles Other | Buy | 72,836 | $6.28 | $457.41K | 2.4% | 3,136,576 | Oct 27, 2025 | — | Form 4 |
| Mosseri Marlio Charles Other | Buy | 35,034 | $6.15 | $215.46K | 1.2% | 3,063,740 | Oct 24, 2025 | — | Form 4 |
| Mosseri Marlio Charles Other | Buy | 46,900 | $6.06 | $284.21K | 1.6% | 3,028,706 | Oct 23, 2025 | — | Form 4 |
| Sanchez Juan Director | Award | 30,000 | — | — | 85.3% | 65,150 | Sep 22, 2025 | — | Form 4 |
What these mean— the action is the SEC’s own Form 4 transaction code. Only a buy or a sell is an open-market trade; the rest are transfers, awards and exercises, which is why they carry no price.
- Buy (P) — Open-market or private purchase
- Award (A) — Grant or award from the company, not a purchase
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.